HomeNewsBusinessMarketsPare your expectations, but follow Warren Buffett's advice! Nifty likely to head towards 17,000 in FY22: Experts

Pare your expectations, but follow Warren Buffett's advice! Nifty likely to head towards 17,000 in FY22: Experts

Investors who managed to conquer their fright and remained invested or added fresh money instead, are smiling at the sight of Multibagger returns in certain stocks. The Nifty50 almost doubled from the closing low of 7,610 recorded on March 23, 2020

March 25, 2021 / 10:18 IST
Story continues below Advertisement

Legendary American investor Warren Buffett once famously said it is wise to be “fearful when others are greedy and greedy when others are fearful.”

Story continues below Advertisement

Applied, from the benefit of hindsight, to the current Indian market situation, it could be considered an apt piece of soliloquy.

Chances are that anyone following Buffett’s investment philosophy might have created wealth in FY21 by staying invested in the mayhem or by entering markets in March last year when both the Sensex and the Nifty suffered double-digit fall on a monthly basis amid the outbreak of COVID.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show